DORB Insider Trading Activity and SEC Form 4 Filings
DORB insider trading summary
No open-market insider purchases or sales of Dor Biopharma Inc (DORB) have been reported on SEC Form 4 in the past 12 months.
Latest DORB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 24, 2009 | Tau International SA Sigma | 10% Owner | Buy | $1000K (3,952,569 @ $0.25) |
| Sep 24, 2009 | America S.A. Sigma-Tau | 10% Owner | Buy | $1000K (3,952,569 @ $0.25) |
| Sep 24, 2009 | Tau Finanziaria Spa Sigma | 10% Owner | Buy | $1000K (3,952,569 @ $0.25) |
| Sep 24, 2009 | Sigma-Tau Pharmaceuticals, Inc. | 10% Owner | Buy | $1000K (3,952,569 @ $0.25) |
| Sep 24, 2009 | Claudio Cavazza | 10% Owner | Buy | $1000K (3,952,569 @ $0.25) |
| Sep 24, 2009 | Paolo Cavazza | 10% Owner | Buy | $1000K (3,952,569 @ $0.25) |
| Feb 11, 2009 | Tau Finanziaria Spa Sigma | 10% Owner | Buy | $4.5M (25,000,000 @ $0.18) |
| Feb 11, 2009 | Tau International SA Sigma | 10% Owner | Buy | $4.5M (25,000,000 @ $0.18) |
| Feb 11, 2009 | Sigma-Tau Pharmaceuticals, Inc. | 10% Owner | Buy | $4.5M (25,000,000 @ $0.18) |
| Feb 11, 2009 | America S.A. Sigma-Tau | 10% Owner | Buy | $4.5M (25,000,000 @ $0.18) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.